Australia's CSL buoyed by trials of new avian flu vaccine

Australia's CSL is testing a vaccine for bird flu that will wrap a 400-person clinical trial in February. Researchers at CSL have said that its vaccine should be able to help prevent an outbreak of human-to-human avian flu unless the H5N1 virus undergoes a major transformation in the mutation process. Under a best case scenario, the company has said that it can vaccinate everyone in Australia within three months of approval, up to six months if higher dosages are needed.

- read this article from the Daily Telegraph for more

PLUS: China said on Sunday that it will shut its borders if it discovers a single case of avian flu that is spread among humans. The UK, meanwhile, confirmed that a parrot that died in isolation had been infected with the virus. Report